Journal of Korean Clinical Health Science (한국임상보건과학회지)

The Korean Society of Clinical Health Science (한국임상보건과학회)
권호 표지
DOI QR코드

DOI QR Code

Role of Radiation Therapy in Oncologic Emergencies

종양응급 상황에서의 방사선치료의 역할

  • Lee, Jun-Ho (Department of Emergency Medical Technology, Daejeon University) ;
  • Baek, Hong-Seok (Department of Emergency Medical Technology, Daejeon University) ;
  • Park, Sang-Sub (Department of Emergency Medical Technology, Chungcheong University) ;
  • Park, Hyun-Suk (Department of Health Service Management, Daejeon University) ;
  • Lee, Seok-Ho (Department of Radiation Oncology, Gachon University Gil Medical Center)
  • 이준호 (대전대학교 응급구조학과) ;
  • 백홍석 (대전대학교 응급구조학과) ;
  • 박상섭 (충청대학교 응급구조학과) ;
  • 박현숙 (대전대학교 병원경영학과) ;
  • 이석호 (가천대학교 길병원 방사선종양학과)
  • Received : 2014.04.06
  • Accepted : 2014.04.20
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose. Radiation therapy for oncologic emergencies is an important modality in the management of cancer patients. The aim of the present study was to review the roles of RT in oncologic emergencies based on literature review. Methods. The oncologic emergencies requiring rapid treatment include superior vena cava syndrome, spinal cord compression, brain metastasis, and bone metastasis. We reviewed the literatures on the pathophysiology, diagnosis, and treatment of oncologic emergencies. Results. In this literature review, radiation therapy among treatment modalities for oncologic emergencies has been shown to be fast and very effective treatment modality for oncologic emergencies. Conclusions. Based on this review, we conclude that the literature provides support for the role of radiation therapy in the situation of oncologic emergencies. As the number of cancer patients increase, the prevalence of oncologic emergencies will increase. In the future, the development of RT techniques will provide the improvement of not only patient's quality of life but also the survival.

Keywords

References

  1. Cervantes A, Chirivella I. Oncological emergencies. Ann Oncol 2004;15 Suppl 4:iv299-306. https://doi.org/10.1093/annonc/mdh943
  2. Cavanna L, Berte R, Bidin L, et al. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases. J Chemother 2005;17:334-338. https://doi.org/10.1179/joc.2005.17.3.334
  3. Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am 2010;24:501-513. https://doi.org/10.1016/j.hoc.2010.03.003
  4. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37-42. https://doi.org/10.1097/01.md.0000198474.99876.f0
  5. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001;CD001316.
  6. Kvale PA, Selecky PA, Prakash UB. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:368S-403S. https://doi.org/10.1378/chest.07-1391
  7. Ostler PJ, Clarke DP, Watkinson AF, et al. Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol) 1997;9:83-89. https://doi.org/10.1016/S0936-6555(05)80445-5
  8. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005;53:373-388;quiz 389-392 https://doi.org/10.1016/j.jaad.2004.09.032
  9. Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am 2009;27:243-255. https://doi.org/10.1016/j.emc.2009.01.003
  10. Slawson RG, Scott RM. Radiation therapy in bronchogenic carcinoma. Radiology 1979;132:175-176. https://doi.org/10.1148/132.1.175
  11. Davenport D, Ferree C, Blake D, et al. Response of superior vena cava syndrome to radiation therapy.Cancer 1976;38:1577-1580. https://doi.org/10.1002/1097-0142(197610)38:4<1577::AID-CNCR2820380422>3.0.CO;2-K
  12. Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc 2006;81:835-848. https://doi.org/10.4065/81.6.835
  13. Schiff D. Spinal cord compression. Neurol Clin 2003;21:67-86, viii. https://doi.org/10.1016/S0733-8619(02)00033-6
  14. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol 2008;7:459-466. https://doi.org/10.1016/S1474-4422(08)70089-9
  15. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-648. https://doi.org/10.1016/S0140-6736(05)66954-1
  16. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005;75:5-14. https://doi.org/10.1007/s11060-004-8093-6
  17. Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-2872. https://doi.org/10.1200/JCO.2004.12.149
  18. SchoutenLJ, Rutten J, Huveneers HA, et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698-2705. https://doi.org/10.1002/cncr.10541
  19. Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol 1988;45:741-744. https://doi.org/10.1001/archneur.1988.00520310047016
  20. Tsao MN, Lloyd NS, Wong RK, et al. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005;31:256-273. https://doi.org/10.1016/j.ctrv.2005.04.007
  21. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-1489.
  22. Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:17-32. https://doi.org/10.1007/s11060-009-0060-9
  23. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751. https://doi.org/10.1016/S0360-3016(96)00619-0
  24. Mintz A, Perry J, Spithoff K, et al. Management of single brain metastasis: a practice guideline. Curr Oncol 2007;14:131-143. https://doi.org/10.3747/co.2007.129
  25. Mehta MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63:37-46. https://doi.org/10.1016/j.ijrobp.2005.05.023
  26. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management ofpatients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:45-68. https://doi.org/10.1007/s11060-009-0073-4
  27. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243s-6249s. https://doi.org/10.1158/1078-0432.CCR-06-0931
  28. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991;9: 509-524. https://doi.org/10.1200/JCO.1991.9.3.509
  29. Lutz S, Lo SS, Chow E, et al. Radiotherapy for metastatic bone disease: current standards and future prospectus. Expert Rev Anticancer Ther 2010;10:683-695. https://doi.org/10.1586/era.10.32
  30. Wu JS, Wong RK, Lloyd NS, et al. Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline. BMC Cancer 2004;4:71. https://doi.org/10.1186/1471-2407-4-71
  31. Roos DE, Turner SL,O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005;75:54-63. https://doi.org/10.1016/j.radonc.2004.09.017
  32. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-128. https://doi.org/10.1093/jnci/djq495
  33. Schiff D, O'Neill BP, Suman VJ. Spinal .epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997;49:452-456. https://doi.org/10.1212/WNL.49.2.452
  34. Stehbens WE. History of aneurysms. Med Hist 1958;2:274-280. https://doi.org/10.1017/S0025727300023978
  35. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 2007;356:1862-1869. https://doi.org/10.1056/NEJMcp067190
  36. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375. https://doi.org/10.1200/JCO.2005.04.754
  37. Kalayci M, Cagavi F, Gul S, et al. Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review. Acta Neurochir (Wien) 2004;146:1347-1354. https://doi.org/10.1007/s00701-004-0386-1
  38. Boogerd W, Hart AA, van der Sande JJ, et al. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991;67:1685-1695. https://doi.org/10.1002/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M
  39. Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol 1978;35:754-756. https://doi.org/10.1001/archneur.1978.00500350058012
  40. Egawa S, Tukiyama I, Akine Y, et al. Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 1986;12:1621-1625. https://doi.org/10.1016/0360-3016(86)90288-9
  41. Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971;111:334-336. https://doi.org/10.2214/ajr.111.2.334
  42. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491. https://doi.org/10.1001/jama.295.21.2483
  43. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-1672. https://doi.org/10.1016/S0140-6736(04)16250-8
  44. Goitein M, Abrams M, Rowell D, et al. Multi-dimensional treatment planning: II. Beam's eye-view, back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys 1983;9:789-797. https://doi.org/10.1016/0360-3016(83)90003-2
  45. Mohan R, Wu Q, Wang X, et al. Intensity modulation optimization, lateral transport of radiation, and margins. Med Phys 1996;23:2011-2021. https://doi.org/10.1118/1.597848
  46. Lee SH, Lee KC, Choi J, et al. Clinical application of RapidArc volumetric modulated arc therapy as a component in whole brain radiation therapy for poor prognostic, four or more multiple brain metastases. Radiat Oncol J 2012;30:53-61. https://doi.org/10.3857/roj.2012.30.2.53
  47. Fong Y, Fortner J, Sun RL,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230: 309-318;discussion 318-321. https://doi.org/10.1097/00000658-199909000-00004